Evidence map›Paper›PMID 37011005›Full record

ArticleMolecular cancer research : MCR2023

EIF4A3 Acts on the PI3K-AKT-ERK1/2-P70S6K Pathway through FLOT1 to Influence the Development of Lung Adenocarcinoma.

Wenhao Yu, Jinghui Liang, Tao Fang, Jin Jiang, Renchang Zhao, Rongyang Li, Jingyi Han, Hui Tian

Open access · hybridAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. GABPA-Mediated Expression of HPN-AS1 Facilitates Cell Apoptosis and Inhibits Cell Proliferation in Hepatocellular Carcinoma by Promoting eIF4A3 Degradation.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Wenhao YuDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.ORCID 0009-0002-6168-1324
Jinghui LiangThe Wistar Institute, Philadelphia, Pennsylvania.ORCID 0000-0002-1425-9406
Tao FangDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.ORCID 0009-0000-0987-6883
Jin JiangDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.ORCID 0009-0009-0127-7179
Renchang ZhaoDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.ORCID 0000-0001-5913-4781
Rongyang LiDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.ORCID 0000-0001-6047-3027
Jingyi HanDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.ORCID 0000-0002-3765-2788
Hui TianDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.ORCID 0000-0002-8932-3003
Qilu Hospital of Shandong University · CNThe Wistar Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD) is a major lung cancer subtype. In this study, we discovered that the eukaryotic translation initiation factor EIF4A3 expression was significantly higher in LUAD tissues and that this higher expression was closely linked to a poor prognosis for LUAD. In addition, we demonstrated that the knockdown of EIF4A3 significantly inhibited the proliferation, invasion, and migration of LUAD cells in vitro and in vivo. The findings of mass spectrometry analysis revealed that EIF4A3 could interact with Flotillin-1 in LUAD cells and that EIF4A3 could positively regulate the expression of FLOT1 at the protein level. Meanwhile, transcriptome sequencing showed that EIF4A3 could influence the development of LUAD by affecting PI3K-AKT-ERK1/2-P70S6K and PI3K class III-mediated autophagy in the Apelin pathway. In addition, we confirmed that Flotillin-1 expression was upregulated in LUAD based on the existing literature, and knockdown of FLOT1 could inhibit the proliferation and migration of LUAD cells. In addition, the knockdown of Flotillin-1 reversed the increase of cell proliferation and migration caused by EIF4A3 overexpression. Furthermore, we found that the activation of PI3K-AKT-ERK1/2-P70S6K signaling pathway and PI3K class III-mediated autophagy caused by EIF4A3 overexpression was rescued by the knockdown of FLOT1. In a word, we proved that EIF4A3 positively regulates the expression of FLOT1 and plays a procancer role in LUAD. IMPLICATIONS: Our study revealed the role of EIF4A3 in prognosis and tumor progression in LUAD, indicating that EIF4A3 could be used as the molecular diagnostic and prognostic therapeutic target.

Indexed as

Adenocarcinoma of LungLung NeoplasmsCell Line, TumorCell MovementCell ProliferationDEAD-box RNA HelicasesEukaryotic Initiation Factor-4AGene Expression Regulation, NeoplasticHumansMAP Kinase Signaling SystemMembrane ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaDEAD-box RNA HelicasesEIF4A3 protein, humanEukaryotic Initiation Factor-4AflotillinsMembrane ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDa

Identifiers

PMID37011005
PMCPMC10320473
OpenAlexW4362507004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.